We chatted to IronRidge Resources' CEO Vincent Mascolo who explains why the company has become a lithium explorer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,991.00
Bid: 6,990.00
Ask: 6,991.00
Change: 46.00 (0.66%)
Spread: 1.00 (0.01%)
Open: 7,025.00
High: 7,075.00
Low: 6,946.00
Yest. Close: 6,945.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

AstraZeneca sees positive results from latest 'anifrolumab' trial

(Sharecast News) - AstraZeneca announced on Thursday that the phase 3 'TULIP 2' trial for 'anifrolumab' - a potential new medicine for the treatment of systemic lupus erythematosus (SLE) - met its primary endpoint, achieving a statistically-significant and clinically-meaningful reduction in disease activity compared to placebo, with both arms receiving standard of care.

29 Aug 19 07:29

Wednesday broker round-up

(Sharecast News) - Greggs: UBS upgrades to buy with a target price of 2,300p.

28 Aug 19 12:43

WINNERS & LOSERS SUMMARY: BP Up As Alaskan Sale Paves Way For Payouts

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - WINNERS----------BP, up

28 Aug 19 10:37

AstraZeneca Gets Breztri Aerosphere Trial Success, Fasenra Orphan Tag

(Alliance News) - AstraZeneca PLC on Wednesday posted positive results from its phase three trial of Breztri Aerosphere and said Fasenra has been granted orphan drug designation in the phase 3 of

28 Aug 19 08:38

AstraZeneca upbeat on progress with 'Fasenra' and 'Breztri Aerosphere'

(Sharecast News) - AstraZeneca announced on Wednesday morning that the US Food and Drug Administration (FDA) has granted 'Orphan Drug Designation' to 'Fasenra' (benralizumab), for the treatment of eosinophilic oesophagitis (EoE).

28 Aug 19 07:38

AstraZeneca upbeat on progress with 'Fasenra' and 'Breztri Aerosphere'

(Sharecast News) - AstraZeneca announced on Wednesday morning that the US Food and Drug Administration (FDA) has granted 'Orphan Drug Designation' to 'Fasenra' (benralizumab), for the treatment of eosinophilic oesophagitis (EoE).

28 Aug 19 07:38

AstraZeneca upbeat on progress with 'Fasenra' and 'Breztri Aerosphere'

(Sharecast News) - AstraZeneca announced on Wednesday morning that the US Food and Drug Administration (FDA) has granted 'Orphan Drug Designation' to 'Fasenra' (benralizumab), for the treatment of eosinophilic oesophagitis (EoE).

28 Aug 19 07:38

AstraZeneca upbeat on progress with 'Fasenra' and 'Breztri Aerosphere'

(Sharecast News) - AstraZeneca announced on Wednesday morning that the US Food and Drug Administration (FDA) has granted 'Orphan Drug Designation' to 'Fasenra' (benralizumab), for the treatment of eosinophilic oesophagitis (EoE).

28 Aug 19 07:38

AstraZeneca upbeat on progress with 'Fasenra' and 'Breztri Aerosphere'

(Sharecast News) - AstraZeneca announced on Wednesday morning that the US Food and Drug Administration (FDA) has granted 'Orphan Drug Designation' to 'Fasenra' (benralizumab), for the treatment of eosinophilic oesophagitis (EoE).

28 Aug 19 07:38

AstraZeneca upbeat on progress with 'Fasenra' and 'Breztri Aerosphere'

(Sharecast News) - AstraZeneca announced on Wednesday morning that the US Food and Drug Administration (FDA) has granted 'Orphan Drug Designation' to 'Fasenra' (benralizumab), for the treatment of eosinophilic oesophagitis (EoE).

28 Aug 19 07:38

AstraZeneca upbeat on progress with 'Fasenra' and 'Breztri Aerosphere'

(Sharecast News) - AstraZeneca announced on Wednesday morning that the US Food and Drug Administration (FDA) has granted 'Orphan Drug Designation' to 'Fasenra' (benralizumab), for the treatment of eosinophilic oesophagitis (EoE).

28 Aug 19 07:38

AstraZeneca upbeat on progress with 'Fasenra' and 'Breztri Aerosphere'

(Sharecast News) - AstraZeneca announced on Wednesday morning that the US Food and Drug Administration (FDA) has granted 'Orphan Drug Designation' to 'Fasenra' (benralizumab), for the treatment of eosinophilic oesophagitis (EoE).

28 Aug 19 07:38

AstraZeneca upbeat on progress with 'Fasenra' and 'Breztri Aerosphere'

(Sharecast News) - AstraZeneca announced on Wednesday morning that the US Food and Drug Administration (FDA) has granted 'Orphan Drug Designation' to 'Fasenra' (benralizumab), for the treatment of eosinophilic oesophagitis (EoE).

28 Aug 19 07:38

AstraZeneca's Farixga Gets US Fast Track Designation In Kidney Disease

(Alliance News) - AstraZeneca PLC on Tuesday said the US has granted fast track designation for the development of Farixga as a treatment for renal failure in chronic kidney disease.The US

27 Aug 19 08:50

China Approves Expanded Release Of AstraZeneca Anaemia Drug

(Alliance News) - AstraZeneca PLC announced Chinese approval for roxadustat in non-dialysis-dependent patients on Thursday, as well as the USD95 million purchase of a priority review voucher in Co

22 Aug 19 08:36

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.